characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: 2018-08-30T17:03:50Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2018-08-28T17:55:25Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA104652039
characteristics.characteristic: External Id
characteristics.text: CNRS / ENS de Lyon
characteristics.characteristic: INSDC center name
characteristics.text: 2018-08-30T17:03:50Z
characteristics.characteristic: INSDC first public
characteristics.text: 2018-08-28T17:55:25Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS2253422
characteristics.characteristic: SRA accession
characteristics.text: IARC385
characteristics.characteristic: Submitter Id
characteristics.text: human
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: common name
characteristics.text: IARC385 was duplicated from the International Agency for Research on Cancer (IARC) library (Lyon, France). IARC385 was obtained by in vitro EBV immortalization of B lymphocytes from the same patient as cell line BL79
characteristics.characteristic: description
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: Homo sapiens
characteristics.characteristic: scientific_name
characteristics.text: IARC385, EBV immortalized B lymphocyte
characteristics.characteristic: title